ALBANY, N.Y., Nov. 8, 2011 (GLOBE NEWSWIRE) -- AngioDynamics (Nasdaq:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, appointed Matthew Kapusta, Senior Vice President of Business Development, effective November 15, 2011, and Donna Haire, Senior Vice President of Regulatory, Quality, Clinical and Medical Affairs, effective immediately. Mr. Kapusta and Ms. Haire will report to President and CEO Joseph M. DeVivo.
